Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model

42Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA immunization is a new approach for cancer immune therapy. In this study, we constructed human papillomavirus (HPV) 16 E7 expression vector cassettes and then compared the abilities of these constructs to induce antitumour protection. Lysosome-targeted E7 antigens, and to a lesser degree signal sequence-conjugated and transmembrane region sequence-conjugated E7 antigens in a DNA form, displayed tumour protection significantly higher than wild-type E7 antigens. This enhanced tumour protection was mediated by CD8 + cytotoxic T lymphocytes (CTL), as determined by in vivo T-cell depletion and in vitro interferon-γ (IFN-γ) production. Subsequent co-injection with interleukin-12-expressing cDNA showed insignificantly enhanced antitumour protection. However, E7 codon optimization plus lysosomal targeting resulted in a dramatic enhancement in antitumour protection both prophylactically and therapeutically through augmentation of the E7-specific CTL population, compared to either one of them alone. However, wild-type or codon-optimized E7 antigens without intracellular targeting displayed no protection against tumour challenge. Thus, these data suggest that antigen codon optimization plus lysosomal targeting strategy could be important in crafting more efficacious E7 DNA vaccines for tumour protection. © 2005 Blackwell Publishing Ltd.

References Powered by Scopus

TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties

7263Citations
N/AReaders
Get full text

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

2731Citations
N/AReaders
Get full text

Human papillomaviruses in the pathogenesis of anogenital cancer

894Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Therapeutic human papillomavirus vaccines: Current clinical trials and future directions

164Citations
N/AReaders
Get full text

mRNA-based cancer vaccine: Prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes

140Citations
N/AReaders
Get full text

DNA vaccines for targeting bacterial infections

113Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kim, M. S., & Sin, J. I. (2005). Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model. Immunology, 116(2), 255–266. https://doi.org/10.1111/j.1365-2567.2005.02219.x

Readers over time

‘10‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

52%

Researcher 7

30%

Professor / Associate Prof. 3

13%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

50%

Medicine and Dentistry 6

33%

Biochemistry, Genetics and Molecular Bi... 2

11%

Pharmacology, Toxicology and Pharmaceut... 1

6%

Save time finding and organizing research with Mendeley

Sign up for free
0